These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 38438738)
1. Genetic variants in m5C modification genes are associated with survival of patients with HBV-related hepatocellular carcinoma. Chen B; Qiu M; Gong R; Liu Y; Zhou Z; Wen Q; Wei X; Liang X; Jiang Y; Chen P; Wei Y; Huang Q; Mo Q; Lin Q; Yu H Arch Toxicol; 2024 Apr; 98(4):1125-1134. PubMed ID: 38438738 [TBL] [Abstract][Full Text] [Related]
2. Genetic variants of m Liu S; Li J; Qiu M; Liu Y; Wen Q; Lin Q; Jiang Y; Zhou Z; Liang X; Wei X; Yu H; Chen P J Cell Mol Med; 2024 Aug; 28(16):e18517. PubMed ID: 39163514 [TBL] [Abstract][Full Text] [Related]
3. Genetic variants of SOS2, MAP2K1 and RASGRF2 in the RAS pathway genes predict survival of HBV-related hepatocellular carcinoma patients. Lin Q; Qiu M; Wei X; Xiang Z; Zhou Z; Ji I; Liang X; Zhou X; Wen Q; Liu Y; Yu H Arch Toxicol; 2023 Jun; 97(6):1599-1611. PubMed ID: 37029817 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus genotypes, expression quantitative trait loci for ZNRD1-AS1 and their interactions in hepatocellular carcinoma. Liu Z; Song C; Wen J; Xu L; Liu Y; Zhu J; Zhu L; Hu Z; Ma H; Liu L Oncotarget; 2016 Jul; 7(28):44076-44083. PubMed ID: 27286450 [TBL] [Abstract][Full Text] [Related]
5. Association between novel genetic variants of Notch signaling pathway genes and survival of hepatitis B virus-related hepatocellular carcinoma. Qin L; Qiu M; Lin Q; Jiang B; Zhan S; Wei X; Wei J; Liu Y; Wen Q; Chen P; Jiang Y; Zhou Z; Liang X; Cao J; Gong Y; Wei Y; Wei X; Yu H Cancer Med; 2024 Apr; 13(7):e7040. PubMed ID: 38562021 [TBL] [Abstract][Full Text] [Related]
6. Potentially functional genetic variants in ferroptosis-related CREB3 and GALNT14 genes predict survival of hepatitis B virus-related hepatocellular carcinoma. Zhan S; Qiu M; Wei X; Wei J; Qin L; Jiang B; Wen Q; Chen P; Lin Q; Wei X; Zhou Z; Jiang Y; Liang X; Li R; Liu Y; Yu H Cancer Med; 2024 Jan; 13(1):e6848. PubMed ID: 38151984 [TBL] [Abstract][Full Text] [Related]
7. Potentially functional genetic variants in RPS6KA4 and MAP2K5 in the MAPK signaling pathway predict HBV-related hepatocellular carcinoma survival. Qiu M; Lin Q; Liu Y; Chen P; Zhou Y; Jiang Y; Zhou Z; Wen Q; Zhou X; Liang X; Gan H; Yu H Mol Carcinog; 2023 Sep; 62(9):1378-1387. PubMed ID: 37278562 [TBL] [Abstract][Full Text] [Related]
8. Transcriptome-wide association study for persistent hepatitis B virus infection and related hepatocellular carcinoma. Han J; Chen C; Wang C; Qin N; Huang M; Ma Z; Zhu M; Dai J; Jiang Y; Ma H; Jin G; Shen H; Hu Z Liver Int; 2020 Sep; 40(9):2117-2127. PubMed ID: 32574393 [TBL] [Abstract][Full Text] [Related]
9. Outer dynein arm docking complex subunit 2 polymorphism rs7893462 modulates hepatocellular carcinoma susceptibility and can serve as an overall survival biomarker for hepatitis B virus-related hepatocellular carcinoma after hepatectomy: a cohort study with a long-term follow-up. Zeng Z; Liao X; Huang K; Han C; Qin W; Su H; Ye X; Yang C; Zhou X; Wei Y; Mo S; Liu J; Lan C; Huang X; Huang Z; Peng K; Gao Q; Peng T; Zhu G World J Surg Oncol; 2023 Oct; 21(1):322. PubMed ID: 37833735 [TBL] [Abstract][Full Text] [Related]
10. Functional genetic variants of the disulfidptosis-related INF2 gene predict survival of hepatitis B virus-related hepatocellular carcinoma. Wei J; Wen Q; Zhan S; Cao J; Jiang Y; Lian J; Mai Y; Qiu M; Liu Y; Chen P; Lin Q; Wei X; Wei Y; Huang Q; Zhang R; He S; Yuan G; Wei Q; Zhou Z; Yu H Carcinogenesis; 2024 Apr; 45(4):199-209. PubMed ID: 38270181 [TBL] [Abstract][Full Text] [Related]
11. Overview of distinct 5-methylcytosine profiles of messenger RNA in human hepatocellular carcinoma and paired adjacent non-tumor tissues. Zhang Q; Zheng Q; Yu X; He Y; Guo W J Transl Med; 2020 Jun; 18(1):245. PubMed ID: 32571340 [TBL] [Abstract][Full Text] [Related]
12. Expression quantitative trait loci for TNFRSF10 influence both HBV infection and hepatocellular carcinoma development. Wen J; Song C; Liu J; Chen J; Zhai X; Hu Z J Med Virol; 2016 Mar; 88(3):474-80. PubMed ID: 26297860 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus-related hepatocellular carcinoma. Yu T; Han C; Zhu G; Liao X; Qin W; Yang C; Liu Z; Su H; Liu X; Yu L; Liu Z; Lu S; Chen Z; Liang Y; Huang J; Qin X; Gui Y; Li J; Peng T Cancer Med; 2017 Jul; 6(7):1587-1600. PubMed ID: 28568708 [TBL] [Abstract][Full Text] [Related]
14. Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence both HBV infection and hepatocellular carcinoma development. Wen J; Liu Y; Liu J; Liu L; Song C; Han J; Zhu L; Wang C; Chen J; Zhai X; Shen H; Hu Z Mol Carcinog; 2015 Nov; 54(11):1275-82. PubMed ID: 25110835 [TBL] [Abstract][Full Text] [Related]
15. Association of PINX1 but not TEP1 Polymorphisms with Progression to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B Virus Infection. Sriprapun M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Tangkijvanich P Asian Pac J Cancer Prev; 2016; 17(4):2019-25. PubMed ID: 27221889 [TBL] [Abstract][Full Text] [Related]
16. Genetic variants in cell death pathway genes and HBV-related hepatocellular carcinoma among a Chinese Han population. Liu F; Li F; Luo L; Yang H; Wei Y; Wang W; Yan L; Wen T; Yang J; Li B Apoptosis; 2017 Aug; 22(8):1035-1047. PubMed ID: 28643196 [TBL] [Abstract][Full Text] [Related]
17. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma. Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128 [TBL] [Abstract][Full Text] [Related]
18. Genetic variants in IL12 influence both hepatitis B virus clearance and HBV-related hepatocellular carcinoma development in a Chinese male population. Tan A; Gao Y; Yao Z; Su S; Jiang Y; Xie Y; Xian X; Mo Z Tumour Biol; 2016 May; 37(5):6343-8. PubMed ID: 26631030 [TBL] [Abstract][Full Text] [Related]
19. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma. Li D; Li K; Zhang W; Yang KW; Mu DA; Jiang GJ; Shi RS; Ke D Front Immunol; 2022; 13():918140. PubMed ID: 35833147 [TBL] [Abstract][Full Text] [Related]
20. ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma. Zhu G; Liao X; Han C; Liu X; Yu L; Qin W; Lu S; Su H; Chen Z; Liu Z; Liang Y; Huang J; Yu T; Yang C; Huang K; Shang L; Ye X; Li L; Qin X; Xiao K; Peng M; Peng T Oncol Rep; 2017 Sep; 38(3):1451-1463. PubMed ID: 28714006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]